Please assess the completion status of the following clinical trial:

Trial Title: AIRVO Device Intervention for Moderate to Severe COPD

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* • Moderate to severe COPD~  * ≥2 inpatient or outpatient claims (ER, or urgent care included) in the previous calendar year~ * ≥2 COPD exacerbations in previous year~ * Current established care within the Reno/Sparks area~ * Residing in Washoe County or Carson City County~ * Ability to travel to site~ * Willing to use myAirVo™2 for at least four hours per day but preferably ≥7 hours or overnight and be capable of handling the myAirVo™2 device after instruction~ * Prior PFT data available prior to admission into project~ * Understand and accept oral and written information in English~ * Life expectancy greater than 1 year~Exclusion Criteria:~* • End-stage renal disease (ESRD)~  * Comorbidity (known malignant disease, terminal illness, dementia, uncontrolled mental illness, COVID-19)~ * Oxygen requirements greater than 6 L/min~ * Bipap or CPAP use in home~ * Receiving hospice care~ * PCP/PI determines the patient is not a good candidate for project inclusion~ * Lung CA~ * Active smoker status

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- AIRVO Device (Type: EXPERIMENTAL): All participants are assigned to this single-arm: Enrolled participants will be given a MyAIRVO2 Device and device stand, and asked to use their device daily, for 12 months

Based on this trial design, predict the completion outcome and termination type (if applicable).